DNA ligases as therapeutic targets.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 24224145)

Published in Transl Cancer Res on June 01, 2013

Authors

Alan E Tomkinson1, Timothy R L Howes, Nathaniel E Wiest

Author Affiliations

1: Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA ; Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA ; University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA.

Articles cited by this

The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem (2010) 9.80

Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell (1995) 9.53

Mechanism of eukaryotic homologous recombination. Annu Rev Biochem (2008) 8.86

IgH class switching and translocations use a robust non-classical end-joining pathway. Nature (2007) 6.05

Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature (1997) 5.08

Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J (1996) 4.89

Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature (1998) 4.37

Single-strand break repair and genetic disease. Nat Rev Genet (2008) 4.07

An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol Cell Biol (1994) 3.99

Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Curr Biol (1999) 3.47

Rag mutations reveal robust alternative end joining. Nature (2007) 3.29

Characterization of the XRCC1-DNA ligase III complex in vitro and its absence from mutant hamster cells. Nucleic Acids Res (1995) 3.03

Two pathways for base excision repair in mammalian cells. J Biol Chem (1996) 3.01

Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol (1999) 2.98

DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes. Mol Cell (1998) 2.97

Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J (2003) 2.94

PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J Biol Chem (1999) 2.92

Human DNA ligase I completely encircles and partially unwinds nicked DNA. Nature (2004) 2.85

DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res (2005) 2.73

Spatial and temporal cellular responses to single-strand breaks in human cells. Mol Cell Biol (2003) 2.70

DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell (2001) 2.69

Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation. Nat Struct Mol Biol (2010) 2.65

Requirement for the Xrcc1 DNA base excision repair gene during early mouse development. Dev Biol (1999) 2.64

Synapsis of DNA ends by DNA-dependent protein kinase. EMBO J (2002) 2.62

XRCC1 protein interacts with one of two distinct forms of DNA ligase III. Biochemistry (1997) 2.46

Eukaryotic DNA ligases: structural and functional insights. Annu Rev Biochem (2008) 2.44

Targeted therapy for cancer using PARP inhibitors. Curr Opin Pharmacol (2008) 2.40

Nucleotide excision repair of DNA with recombinant human proteins: definition of the minimal set of factors, active forms of TFIIH, and modulation by CAK. Genes Dev (2000) 2.29

DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation. PLoS Genet (2011) 2.22

Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells. PLoS Genet (2010) 2.14

Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents. Cell (1992) 2.13

DNA ligase I is recruited to sites of DNA replication by an interaction with proliferating cell nuclear antigen: identification of a common targeting mechanism for the assembly of replication factories. EMBO J (1998) 2.10

Crystal structure of an Xrcc4-DNA ligase IV complex. Nat Struct Biol (2001) 2.07

A backup DNA repair pathway moves to the forefront. Cell (2007) 1.97

The human DNA ligase III gene encodes nuclear and mitochondrial proteins. Mol Cell Biol (1999) 1.94

Sealing of chromosomal DNA nicks during nucleotide excision repair requires XRCC1 and DNA ligase III alpha in a cell-cycle-specific manner. Mol Cell (2007) 1.89

Mammalian DNA ligases. Catalytic domain and size of DNA ligase I. J Biol Chem (1990) 1.84

An interaction between DNA ligase I and proliferating cell nuclear antigen: implications for Okazaki fragment synthesis and joining. Proc Natl Acad Sci U S A (1997) 1.82

An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression. Cell (2012) 1.81

Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair. Nature (2011) 1.80

Interaction between PCNA and DNA ligase I is critical for joining of Okazaki fragments and long-patch base-excision repair. Curr Biol (2000) 1.78

An alternative splicing event which occurs in mouse pachytene spermatocytes generates a form of DNA ligase III with distinct biochemical properties that may function in meiotic recombination. Mol Cell Biol (1997) 1.71

DNA ligase III is recruited to DNA strand breaks by a zinc finger motif homologous to that of poly(ADP-ribose) polymerase. Identification of two functionally distinct DNA binding regions within DNA ligase III. J Biol Chem (1999) 1.66

Requirement for an interaction of XRCC4 with DNA ligase IV for wild-type V(D)J recombination and DNA double-strand break repair in vivo. J Biol Chem (1998) 1.66

The N-terminal domain of human DNA ligase I contains the nuclear localization signal and directs the enzyme to sites of DNA replication. EMBO J (1995) 1.59

Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks. Blood (2008) 1.48

DNA ligase III is critical for mtDNA integrity but not Xrcc1-mediated nuclear DNA repair. Nature (2011) 1.45

Structural and functional interaction between the human DNA repair proteins DNA ligase IV and XRCC4. Mol Cell Biol (2009) 1.43

Early embryonic lethality due to targeted inactivation of DNA ligase III. Mol Cell Biol (2006) 1.38

DNA ligase I is required for fetal liver erythropoiesis but is not essential for mammalian cell viability. Nat Genet (1996) 1.37

Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair. Cancer Res (2008) 1.36

Analysis of DNA ligase IV mutations found in LIG4 syndrome patients: the impact of two linked polymorphisms. Hum Mol Genet (2004) 1.33

Human DNA ligase III recognizes DNA ends by dynamic switching between two DNA-bound states. Biochemistry (2010) 1.32

Robust chromosomal DNA repair via alternative end-joining in the absence of X-ray repair cross-complementing protein 1 (XRCC1). Proc Natl Acad Sci U S A (2012) 1.31

Two DNA-binding and nick recognition modules in human DNA ligase III. J Biol Chem (2008) 1.30

Reconstitution of proliferating cell nuclear antigen-dependent repair of apurinic/apyrimidinic sites with purified human proteins. J Biol Chem (1999) 1.28

Mitochondrial DNA ligase III function is independent of Xrcc1. Nucleic Acids Res (2000) 1.24

DNA ligase I null mouse cells show normal DNA repair activity but altered DNA replication and reduced genome stability. J Cell Sci (2002) 1.18

Structure of an Xrcc4-DNA ligase IV yeast ortholog complex reveals a novel BRCT interaction mode. DNA Repair (Amst) (2006) 1.18

Antisense-mediated decrease in DNA ligase III expression results in reduced mitochondrial DNA integrity. Nucleic Acids Res (2001) 1.13

NHEJ and its backup pathways in chromosomal translocations. Nat Struct Mol Biol (2010) 1.11

Identification and validation of human DNA ligase inhibitors using computer-aided drug design. J Med Chem (2008) 1.10

BRCT domain interactions in the heterodimeric DNA repair protein XRCC1-DNA ligase III. Biochemistry (2001) 1.10

Cells from an immunodeficient patient (46BR) with a defect in DNA ligation are hypomutable but hypersensitive to the induction of sister chromatid exchanges. Proc Natl Acad Sci U S A (1985) 1.08

Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: implications for genomic instability and therapy. Blood (2010) 1.07

Targeting abnormal DNA repair in therapy-resistant breast cancers. Mol Cancer Res (2011) 1.07

Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias. Oncogene (2012) 1.05

Functional redundancy between DNA ligases I and III in DNA replication in vertebrate cells. Nucleic Acids Res (2011) 1.03

Role of the DNA ligase III zinc finger in polynucleotide binding and ligation. Nucleic Acids Res (1998) 0.98

Multiple hypersensitivity to mutagens in a cell strain (46BR) derived from a patient with immuno-deficiencies. Mutat Res (1983) 0.97

Replication failure, genome instability, and increased cancer susceptibility in mice with a point mutation in the DNA ligase I gene. Cancer Res (2002) 0.96

A biochemical defect in the repair of alkylated DNA in cells from an immunodeficient patient (46BR). Carcinogenesis (1983) 0.93

The structural basis for partitioning of the XRCC1/DNA ligase III-α BRCT-mediated dimer complexes. Nucleic Acids Res (2011) 0.93

Translocation of XRCC1 and DNA ligase IIIalpha from centrosomes to chromosomes in response to DNA damage in mitotic human cells. Nucleic Acids Res (2005) 0.92

Natural-product inhibitors of human DNA ligase I. Biochem J (1996) 0.91

Phosphorylation of human DNA ligase I regulates its interaction with replication factor C and its participation in DNA replication and DNA repair. Mol Cell Biol (2009) 0.91

Disconnecting XRCC1 and DNA ligase III. Cell Cycle (2011) 0.90

A high-throughput scintillation proximity-based assay for human DNA ligase IV. Assay Drug Dev Technol (2011) 0.88

Elevated expression of DNA ligase I in human cancers. Clin Cancer Res (2001) 0.87

Structural basis of DNA ligase IV-Artemis interaction in nonhomologous end-joining. Cell Rep (2012) 0.86

Development of non-electrophoretic assay method for DNA ligases and its application to screening of chemical inhibitors of DNA ligase I. J Biochem Biophys Methods (2004) 0.83

Partial complementation of a DNA ligase I deficiency by DNA ligase III and its impact on cell survival and telomere stability in mammalian cells. Cell Mol Life Sci (2012) 0.81

DNA ligase I, the replicative DNA ligase. Subcell Biochem (2012) 0.79